COVID-19 Will Spur Decentralized and Hybrid Trials – Novartis Hails Digital Investment

Decentralized Trials Can Only Soften The Blow

 
• By Andrew McConaghie
  
Novartis_Building
Novartis says its investment in digitizing clinical trial monitoring has helped during the crisis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip